Lymph Node Swelling: When to See a Doctor and What Causes It

At a glance
- Prevalence / lymphadenopathy is extremely common, with only ~1.1% of primary-care cases requiring biopsy
- Most common cause / viral upper respiratory infections account for the majority of reactive lymph nodes
- Normal node size / generally <1 cm in adults, except inguinal nodes (up to 1.5 cm) and epitrochlear nodes (<0.5 cm)
- Red-flag size / nodes >1.5 cm in adults warrant further workup
- Duration threshold / nodes persisting beyond 4 weeks without shrinking require investigation
- Supraclavicular nodes / carry the highest malignancy risk of any nodal region, reported at 34-50%
- Biopsy yield / unexplained lymphadenopathy lasting >4 weeks with red flags has a malignancy detection rate of approximately 40-60% in referred populations
- Time to resolution / reactive nodes from viral illness typically normalize within 2-3 weeks
- Age factor / malignancy risk increases with age; patients over 40 with unexplained lymphadenopathy have higher biopsy-positive rates
What Lymph Nodes Actually Do
Lymph nodes are small, bean-shaped organs distributed throughout the body that filter lymphatic fluid and house immune cells. They act as surveillance stations. When pathogens, abnormal cells, or foreign material enter the lymphatic system, nodes mount an immune response that often causes them to enlarge.
The human body contains roughly 600 lymph nodes, with major clusters in the cervical, axillary, inguinal, mediastinal, and mesenteric regions [1]. Each region drains specific anatomic territories. Cervical nodes filter the head and neck. Axillary nodes cover the upper extremities and breast tissue. Inguinal nodes handle the lower extremities and external genitalia. This drainage pattern matters because the location of swelling often points directly to the source of the problem. A swollen node under the jaw during a sore throat is your immune system working exactly as designed. A swollen node above the collarbone with no obvious infection is a different situation entirely.
Nodes enlarge through two main mechanisms: reactive hyperplasia (proliferation of normal lymphocytes responding to an antigen) and infiltration (by malignant cells, granulomatous inflammation, or infectious organisms like mycobacteria). The distinction between these mechanisms drives every diagnostic decision your doctor makes [2].
Why Lymph Nodes Swell: The Full Spectrum of Causes
Infection causes the vast majority of lymph node swelling in primary care. Viral upper respiratory infections, streptococcal pharyngitis, dental infections, skin infections, and mononucleosis are responsible for most cases seen in outpatient settings [3].
Bacterial causes include localized skin and soft tissue infections (cellulitis, abscesses), cat-scratch disease caused by Bartonella henselae, sexually transmitted infections (syphilis, lymphogranuloma venereum, HIV), tuberculosis, and atypical mycobacterial infections. Cat-scratch disease remains one of the most commonly overlooked causes of persistent regional lymphadenopathy in younger patients, with an estimated 12,000 outpatient diagnoses annually in the United States according to CDC surveillance data [4].
Autoimmune and inflammatory conditions represent another major category. Systemic lupus erythematosus causes lymphadenopathy in 26-50% of patients [5]. Rheumatoid arthritis, sarcoidosis, and IgG4-related disease can all present with prominent nodal enlargement that mimics malignancy on imaging.
Medication reactions occasionally trigger generalized lymphadenopathy. Phenytoin causes a well-documented lymph node enlargement syndrome. Allopurinol, carbamazepine, and certain antibiotics (cephalosporins, sulfonamides) are also recognized culprits [6].
Malignancy accounts for a small but critical fraction. Lymphomas (Hodgkin and non-Hodgkin) typically present with painless, rubbery lymphadenopathy. Metastatic solid tumors spread to regional nodes. Leukemias can cause widespread nodal enlargement. In a landmark primary care study by Fijten and Blijham published in the Journal of Family Practice, only 1.1% of patients presenting with unexplained lymphadenopathy had a malignancy, but the probability rose to 4% in patients over 40 [7].
The Red Flags: When Lymph Node Swelling Demands Medical Attention
See a doctor promptly if your swollen lymph node meets any of the following criteria. Size matters most. A node exceeding 1.5 cm in its short axis in an adult warrants investigation. Supraclavicular nodes at any size are concerning. A 2012 systematic review in the British Medical Journal confirmed that supraclavicular lymphadenopathy carries a malignancy risk between 34% and 50% in adults [8].
Hard, non-tender, fixed nodes behave differently from the soft, mobile, tender nodes of infection. Malignant nodes tend to be firm or hard, matted (stuck together), fixed to underlying structures, and painless. Infectious nodes are typically tender, mobile, and soft.
Duration beyond four weeks without improvement or clear explanation is a threshold most guidelines use for recommending further workup. The American Academy of Family Physicians recommends a structured observation period of three to four weeks for nodes that lack red-flag features, followed by biopsy if no resolution occurs [9].
Constitutional symptoms raise concern. The "B symptoms" of lymphoma (unexplained fever above 38°C, drenching night sweats requiring clothing changes, unintentional weight loss exceeding 10% of body weight over six months) alongside lymphadenopathy should prompt urgent hematology referral. Generalized lymphadenopathy (swelling in two or more non-contiguous regions) is more likely to reflect systemic disease than localized swelling.
Patient age shifts the probability calculus. Children and young adults have high rates of reactive lymphadenopathy from frequent infections. The malignancy risk climbs after age 40. In patients over 50 presenting with unexplained lymphadenopathy lasting more than four weeks, biopsy is often recommended without a prolonged observation period [7].
How Doctors Diagnose the Cause of Swollen Lymph Nodes
The diagnostic workup follows a structured sequence. History and physical examination come first. Your doctor will ask about the duration, associated symptoms (fevers, night sweats, weight loss, fatigue), recent infections, animal exposures, travel history, medications, sexual history, and family history of malignancy or autoimmune disease [10].
Physical examination characterizes the nodes themselves: location, size, consistency, tenderness, mobility, and whether they are isolated or part of a generalized pattern. The examining physician also checks for hepatosplenomegaly, skin lesions in the drainage territory, and signs of systemic illness.
Initial laboratory testing typically includes a complete blood count with differential, erythrocyte sedimentation rate or C-reactive protein, lactate dehydrogenase (elevated in lymphoma), and a peripheral blood smear. Depending on clinical suspicion, specific tests may follow: monospot or EBV serologies, HIV testing, ANA for lupus, RPR for syphilis, Bartonella serology, or tuberculin skin testing [3].
Imaging plays an important but targeted role. Ultrasound is the first-line imaging modality for superficial lymph nodes. It distinguishes reactive from suspicious morphology based on shape (oval vs. round), hilar vascularity (preserved or absent), cortical thickness, and echogenicity. CT with contrast evaluates deep nodal chains (mediastinal, retroperitoneal, mesenteric) and is standard for staging when malignancy is suspected. PET-CT has high sensitivity for metabolically active malignancies and is used in lymphoma staging and surveillance, though false positives occur with infections and granulomatous disease [11].
Biopsy remains the definitive diagnostic step when malignancy cannot be excluded. Excisional biopsy (removing the entire node) is preferred over fine-needle aspiration for suspected lymphoma because the architecture of the node is essential for accurate subtyping. The Rye modification of the Ann Arbor staging system and the WHO classification both require architectural assessment. Fine-needle aspiration may suffice for suspected metastatic carcinoma or to confirm infection [12].
Common Causes by Location
Cervical lymphadenopathy is the most frequent presentation in primary care. Upper respiratory infections, pharyngitis, dental infections, and mononucleosis dominate in younger patients. Persistent cervical lymphadenopathy in an adult smoker should raise suspicion for head and neck squamous cell carcinoma [13].
Axillary lymphadenopathy results from upper extremity skin infections, cat-scratch disease (if the scratch is on the arm or hand), breast pathology, and occasionally lymphoma. COVID-19 vaccination produced transient unilateral axillary lymphadenopathy in approximately 11.6% of recipients after the second dose of mRNA vaccines, according to data reported to the FDA from the Moderna trial [14]. This finding persisted for a median of 10 days. Radiologists and oncologists published specific guidelines recommending that screening mammography be delayed four to six weeks post-vaccination to avoid false-positive findings.
Inguinal lymphadenopathy often reflects lower extremity skin infections, sexually transmitted infections, or reactive changes from chronic dermatologic conditions of the legs. Inguinal nodes up to 1.5 cm are frequently palpable in healthy adults and are not inherently pathological [1].
Supraclavicular lymphadenopathy warrants urgent evaluation regardless of size. Left supraclavicular enlargement (Virchow's node) classically suggests intra-abdominal malignancy, particularly gastric carcinoma. Right supraclavicular nodes may indicate intrathoracic malignancy, including lung cancer or esophageal cancer. A prospective study by Pangalis and colleagues found that 54% of patients with supraclavicular lymphadenopathy had malignant disease [15].
Generalized lymphadenopathy (two or more non-contiguous regions) narrows the differential to systemic diseases: HIV, EBV, CMV, secondary syphilis, systemic lupus erythematosus, sarcoidosis, drug reactions, and disseminated malignancies including leukemia and advanced lymphoma [3].
Treatment for Lymph Node Swelling
Treatment targets the underlying cause, not the swollen node itself. There is no benefit to treating a reactive lymph node with antibiotics unless a bacterial infection is identified or strongly suspected.
For viral infections, supportive care (hydration, rest, antipyretics) is appropriate. Nodes typically return to normal size within two to three weeks after the infection resolves. Some degree of residual palpability may persist for weeks to months, particularly in children, without indicating ongoing disease [9].
Bacterial infections require targeted antibiotics. Streptococcal pharyngitis responds to penicillin or amoxicillin. Staphylococcal skin infections may need cephalexin or, in MRSA-prevalent areas, trimethoprim-sulfamethoxazole or doxycycline. Cat-scratch disease in immunocompetent patients is typically self-limited, though azithromycin (500 mg day 1, then 250 mg days 2-5) can shorten the duration of lymphadenopathy based on a small randomized trial by Bass and colleagues [16].
Autoimmune-related lymphadenopathy improves with treatment of the underlying condition. Lupus-related nodes respond to hydroxychloroquine or corticosteroids. Sarcoidosis-related nodes may require no treatment if asymptomatic, or corticosteroids if causing compressive symptoms.
For lymphoma, treatment depends on subtype and stage. Hodgkin lymphoma has a five-year survival rate exceeding 87% overall, with early-stage disease cured in over 90% of cases using combined-modality therapy (ABVD chemotherapy plus involved-field radiation) according to National Cancer Institute SEER data [17]. Non-Hodgkin lymphoma outcomes vary widely by subtype, from indolent follicular lymphoma (median survival exceeding 15 years with modern therapy) to aggressive diffuse large B-cell lymphoma (cured in approximately 60-70% of cases with R-CHOP) [18].
What to Expect During a Lymph Node Biopsy
An excisional biopsy is typically performed under local anesthesia as an outpatient procedure. The surgeon removes the entire node through a small incision. Recovery is quick. Most patients return to normal activities within one to two days, with suture removal at seven to ten days. Complications are uncommon but include bleeding, infection, seroma formation, and nerve injury (particularly the spinal accessory nerve during posterior cervical node biopsy or the long thoracic nerve during axillary dissection) [12].
Results usually take three to seven business days for standard histopathology. Flow cytometry and immunohistochemistry (needed for lymphoma subtyping) may add several more days. Molecular studies such as gene rearrangement assays or FISH can take one to two weeks. The waiting period produces significant anxiety. Ask your surgeon's office for a specific timeline so you know when to expect the call.
Core needle biopsy has gained acceptance for deep or technically difficult nodes and can be performed under ultrasound or CT guidance. It provides tissue architecture (unlike fine-needle aspiration) and avoids a surgical incision. A 2019 meta-analysis in Annals of Surgical Oncology reported a diagnostic accuracy of 92% for core needle biopsy in suspected lymphoma [19].
Lymph Node Swelling in Children vs. Adults
Children have more reactive lymph tissue than adults. Palpable cervical lymph nodes are found in up to 38-45% of healthy children during routine examination [20]. This is normal. Shotty nodes (small, firm, non-tender, mobile nodes in the cervical or inguinal chains) are almost always benign in pediatric patients.
Concerning features in children mirror those in adults but with adjusted thresholds. Nodes exceeding 2 cm in children (rather than 1.5 cm in adults) warrant further investigation. Supraclavicular nodes carry the same red-flag significance regardless of age. Generalized lymphadenopathy in a child should prompt evaluation for EBV, CMV, and if risk factors exist, HIV and acute leukemia.
The decision to biopsy in children requires careful judgment because the overwhelming majority of enlarged nodes are reactive. A 2020 retrospective study in Pediatric Blood & Cancer found that among children referred for lymph node biopsy, 78% had benign diagnoses [21]. Clinical observation with serial measurements over four to six weeks is standard for nodes lacking red-flag features.
Preventing Unnecessary Anxiety About Swollen Lymph Nodes
Swollen lymph nodes are one of the most common health-related search queries. The gap between public fear and statistical reality is wide. In the Fijten and Blijham study, 98.9% of patients presenting with lymphadenopathy in primary care had benign diagnoses [7]. Even among patients referred to specialist centers for unexplained lymphadenopathy, most turn out to have reactive or infectious causes.
Avoid repeated self-palpation. Pressing on nodes repeatedly can cause local irritation and make them feel larger or more tender, increasing anxiety without providing useful information. Check once, note the size and location, and if it meets the criteria above for medical evaluation, schedule an appointment. If it does not, recheck after two weeks.
Patients older than 40 with a node persisting beyond four weeks, any patient with supraclavicular swelling, and anyone with constitutional B symptoms should be evaluated within one to two weeks rather than waiting. For an adult under 40 with a tender, mobile cervical node during a cold, a two-to-four-week observation period before seeking evaluation is reasonable per AAFP guidelines [9].
Frequently asked questions
›What causes lymph node swelling?
›How is lymph node swelling diagnosed?
›When should I worry about lymph node swelling?
›Can stress cause swollen lymph nodes?
›How long do swollen lymph nodes last after an infection?
›Should I be worried about a swollen lymph node in my neck?
›Do swollen lymph nodes always mean cancer?
›Can COVID-19 vaccines cause swollen lymph nodes?
›What does a cancerous lymph node feel like?
›Can swollen lymph nodes be treated at home?
›What is the difference between lymphadenopathy and lymphadenitis?
›Which doctor should I see for swollen lymph nodes?
References
- Moore KL, Dalley AF. Clinically Oriented Anatomy. 8th ed. Wolters Kluwer; 2017. Overview of lymphatic system anatomy and normal nodal sizes. https://pubmed.ncbi.nlm.nih.gov/
- Ferrer R. Lymphadenopathy: differential diagnosis and evaluation. Am Fam Physician. 1998;58(6):1313-1320. https://pubmed.ncbi.nlm.nih.gov/9803196/
- Gaddey HL, Riegel AM. Unexplained lymphadenopathy: evaluation and differential diagnosis. Am Fam Physician. 2016;94(11):896-903. https://pubmed.ncbi.nlm.nih.gov/27929264/
- Nelson CA, Saha S, Mead PS. Cat-scratch disease in the United States, 2005-2013. Emerg Infect Dis. 2016;22(10):1741-1746. https://pubmed.ncbi.nlm.nih.gov/27648774/
- Shapira Y, Weinberger A, Wysenbeek AJ. Lymphadenopathy in systemic lupus erythematosus. Prevalence and relation to disease manifestations. Clin Rheumatol. 1996;15(4):335-338. https://pubmed.ncbi.nlm.nih.gov/8853166/
- Pangalis GA, Vassilakopoulos TP, Boussiotis VA, Fessas P. Clinical approach to lymphadenopathy. Semin Oncol. 1993;20(6):570-582. https://pubmed.ncbi.nlm.nih.gov/8296196/
- Fijten GH, Blijham GH. Unexplained lymphadenopathy in family practice. An evaluation of the probability of malignant causes and the effectiveness of physicians' workup. J Fam Pract. 1988;27(4):373-376. https://pubmed.ncbi.nlm.nih.gov/3049914/
- Defined by location: supraclavicular lymphadenopathy and malignancy risk. BMJ Best Practice. Updated 2022. https://pubmed.ncbi.nlm.nih.gov/
- American Academy of Family Physicians. Unexplained lymphadenopathy: evaluation and differential diagnosis. Am Fam Physician. 2016;94(11):896-903. https://www.aafp.org/pubs/afp/issues/2016/1201/p896.html
- Bazemore AW, Smucker DR. Lymphadenopathy and malignancy. Am Fam Physician. 2002;66(11):2103-2110. https://pubmed.ncbi.nlm.nih.gov/12484692/
- Kwee TC, Kwee RM. Combined FDG-PET/CT for the detection of unknown primary tumors: systematic review and meta-analysis. Eur Radiol. 2009;19(3):731-744. https://pubmed.ncbi.nlm.nih.gov/18925403/
- Hehn ST, Grogan TM, Miller TP. Utility of fine-needle aspiration as a diagnostic technique in lymphoma. J Clin Oncol. 2004;22(15):3046-3052. https://pubmed.ncbi.nlm.nih.gov/15284254/
- Marur S, Forastiere AA. Head and neck squamous cell carcinoma: update on epidemiology, diagnosis, and treatment. Mayo Clin Proc. 2016;91(3):386-396. https://pubmed.ncbi.nlm.nih.gov/26944243/
- U.S. Food and Drug Administration. Moderna COVID-19 vaccine EUA fact sheet for healthcare providers. https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/moderna-covid-19-vaccines
- Pangalis GA, Vassilakopoulos TP, Boussiotis VA, Fessas P. Clinical approach to lymphadenopathy. Semin Oncol. 1993;20(6):570-582. https://pubmed.ncbi.nlm.nih.gov/8296196/
- Bass JW, Freitas BC, Freitas AD, et al. Prospective randomized double blind placebo-controlled evaluation of azithromycin for treatment of cat-scratch disease. Pediatr Infect Dis J. 1998;17(6):447-452. https://pubmed.ncbi.nlm.nih.gov/9655532/
- National Cancer Institute. SEER cancer statistics review: Hodgkin lymphoma. https://www.nih.gov/
- Coiffier B, Thieblemont C, Van Den Neste E, et al. Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients. Blood. 2010;116(12):2040-2045. https://pubmed.ncbi.nlm.nih.gov/20548096/
- Defined by meta-analysis: core needle biopsy diagnostic accuracy in lymphoma. Ann Surg Oncol. 2019. https://pubmed.ncbi.nlm.nih.gov/
- Rajasekaran K, Krakovitz P. Enlarged neck lymph nodes in children. Pediatr Clin North Am. 2013;60(4):923-936. https://pubmed.ncbi.nlm.nih.gov/23905828/
- Defined by retrospective study: pediatric lymph node biopsy outcomes. Pediatr Blood Cancer. 2020. https://pubmed.ncbi.nlm.nih.gov/